Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Utah for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Utah only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Utah (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

David Faber (NPI 1811990450)

Field	Value
Entity Type	Individual
Organization	David Faber
Address	4400 S 700 E
City	Salt Lake City
State	UT
ZIP	84107
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	May 27, 2005

Payer Source	Total Paid
Medicare	$4M
Medicaid	$0

Key Findings

DAVID FABER is a retina specialist in SALT LAKE CITY, UT with an NPI enumerated 2005-05-27 (~21 years ago). Lifetime Medicare revenue on file is $4M and there is no Medicaid billing on file, indicating this profile is effectively a Medicare-only billing footprint in the available data.

Revenue is highly concentrated in a small set of drug/injection codes: the top 3 Medicare codes (J0178, J3490, J2777) account for 86.7% of this provider's total Medicare revenue. Those three codes individually contribute $2.5M (J0178), $762.7K (J3490), and $189.7K (J2777) to the $4M Medicare total, signaling dependence on a narrow group of high-dollar services.

The code mix is characteristic of an intravitreal injection–focused retina practice: J0178 (aflibercept) is the dominant revenue driver at $2.5M and 62.6% of Medicare revenue, supplemented by other drug administration codes J3490 and J2777. This pattern — high-volume anti-VEGF billing combined with intravitreal injection procedure codes (67028) — indicates clinical operations centered on medical retinal management rather than primarily surgical retina care.

J0178 is a national high-volume outlier for this provider (rank #101 of 3204, 97th percentile) and is explicitly described as notably above typical national volume, making the provider a major national participant for aflibercept administration. By contrast, J3490 appears as $762.7K and ranks #162 of 2838 (94th percentile) but is labeled in the data as typical, unremarkable volume for that code, and J2777 ($189.7K) ranks lower (#1335 of 2039, 34th percentile) with a similar label of typical, unremarkable volume — together these ranks suggest exceptional dominance specifically in J0178 while other drug codes are more routine.

Supporting services and office-based care are also notable and track with an injection-heavy practice: 99214 ($64.3K, rank #23937 of 479517, 95th percentile), 92134 ($52.2K, rank #1224 of 26868, 95th percentile), and 99213 ($35.8K, rank #19584 of 457151, 96th percentile) are all described as notably above typical national volume. This mix indicates steady ambulatory evaluation/management and retinal imaging volume that supports frequent therapeutic injections.

Surgical retinal procedure volume is comparatively modest. 67028 (vitreous injection as a separate procedure) generates $180K (4.5% of Medicare revenue) and ranks #413 of 4255 (90th percentile) but is still characterized as typical, unremarkable volume; more invasive surgical CPTs (67036, 67108, 67041) account for small shares of revenue and sit at mid-to-lower national ranks, indicating the practice does some surgery but is not primarily surgical in its Medicare billing footprint.

The second-largest revenue bucket is J3490 (Unclassified drugs) at $762.7K (19.3% of Medicare revenue), which is notable because it represents almost one-fifth of Medicare revenue despite being labeled typical/unremarkable in volume. That concentration suggests a material portion of drug-related revenue flows through unclassified billing lines rather than a larger set of specific HCPCS codes, which has implications for payers and contracting teams when reviewing drug-related reimbursement detail.

From a payer mix and contracting perspective, this provider is effectively single-payer in the available dataset: $4M in Medicare revenue and no Medicaid billing on file. Analysts evaluating network adequacy, utilization, or negotiations should treat this as a Medicare-centric revenue profile and focus competitive benchmarking on Medicare drug and injection volumes rather than on state Medicaid comparisons.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

19 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	3,580	$690	$2.5M
J3490	Unclassified drugs	350	$2,170	$762.7K
J2777	Injection, faricimab‑svoa, 0.1 mg	6,540	$30	$189.7K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,980	$90	$180K
J2778	Injection, ranibizumab, 0.1 mg	420	$190	$77.2K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	730	$90	$64.3K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	1,800	$30	$52.2K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	600	$60	$35.8K
J7312	Injection, dexamethasone, intravitreal implant, 0.1 mg	180	$160	$28.6K
Q5128	Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg	120	$220	$25.9K

Showing 1–10 of 19

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 19 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Utah Distribution

David Faber — 4 of 19 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Utah

Full comparison — all codes billed, vs. state median

19 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	2	40	620	$690	$683.2K
J2777	19	20	13,140	$30	$523.9K
J2778	7	10	870	$180	$224.3K
J3490	2	30	80	$1,690	$199.5K
Q5128	4	10	290	$220	$69.1K
67028	4	60	440	$90	$61.7K
J7312	7	10	340	$160	$52.7K
67041	6	10	20	$1,040	$28.2K
67036	11	20	20	$1,010	$24.2K
67108	7	10	20	$1,090	$18.6K

Showing 1–10 of 19

Related Providers

Other providers that share a Tax Identification Number (TIN) with David Faber, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Mitchell Goff	UT	Retina Specialist (Ophthalmology) Physician	$3.8M	$0
Jack Stringham	UT	Retina Specialist (Ophthalmology) Physician	$3.4M	$0
Michael Simmons	UT	Ophthalmology Physician	$1.2M	$0
Rocky Mountain Retina Consultants	UT	Retina Specialist (Ophthalmology) Physician	$0	$690.7K
Peter Hurlbut-miller	HI	Retina Specialist (Ophthalmology) Physician	$509.4K	$0

Nearby Providers

Other providers in the same ZIP code as David Faber, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Ihc Health Services, Inc.	UT	General Acute Care Hospital	$0	$68.7M
Ihc Health Services, Inc.	UT	Clinical Medical Laboratory	$2.7M	$17.9M
Alpine Home Medical Equipment LLC	UT	Oxygen Equipment & Supplies (DME)	$0	$18.6M
Ddi Vantage	UT	Developmentally Disabled Services Day Training Agency	$0	$18.4M
Utah Emergency Physicians	UT	Emergency Medicine Physician	$0	$14.5M
Home Caregivers Partnership, LLC	UT	Home Health Agency	$0	$10.4M
Gcs Foundation	UT	Supports Brokerage Agency	$0	$6.2M
Ihc Health Services Inc	UT	Diagnostic Radiology Physician	$0	$6.1M
Joel Herring	UT	Retina Specialist (Ophthalmology) Physician	$5.6M	$23.7K
Project Reality	UT	Mental Health Counselor	$0	$5.1M

David Faber — Billing Profile & Reimbursement Data

Sign up for David Faber — Billing Profile & Reimbursement Data policy alerts

David Faber — Billing Profile & Reimbursement Data

Sign up for David Faber — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References